Yueyang Pharmaceutical Development

Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd. is an innovative pharmaceutical development entity and an associate of Shanghai Pharmaceuticals Holding Co., Ltd. The company focuses on the research, development, and commercialization of a diverse pipeline of innovative drugs, including small molecules and biologics. Its portfolio covers therapeutic areas such as cardiovascular diseases, oncology, and infectious diseases, with key programs like I001 for hypertension in late-stage clinical development. As a strategic investment of Shanghai Pharma, the company plays a significant role in the group's innovation ecosystem, leveraging regional resources in the Greater Bay Area to advance its clinical programs.